Exposure of cultured endothelium to environments with low concentrations of oxygen, in the range of those observed in pathophysiologic hypoxemic states in vivo, compromises cellular barrier and coagulant function. An atmosphere with PO2 approximately 14 mm Hg was not lethally toxic to endothelial cultures, but cells became larger and exhibited small intercellular gaps. At low oxygen concentrations, passage of macromolecular tracers through hypoxic endothelial monolayers was accelerated in a time-and dose-dependent manner, presumably by a paracellular pathway via the gaps. Cell surface coagulant properties of the endothelium were also perturbed. At PO2 approximately 14 mm Hg thrombomodulin antigen and functional activity on the cell surface were diminished by 80-90%, and Northern blots demonstrated suppression of thrombomodulin mRNA. The decrease in thrombomodulin was twice as great compared with the general decline in total protein synthesis in hypoxia. In addition, expression of a direct Factor X activator developed under hypoxic conditions; the activator was membrane-associated and expressed on the surface of intact cultures, Ca-dependent, inhibited by HgCl2 but not PMSF, and had Km approximately 25 micrograms/ml for the substrate at pH 7.4. Synthesis of the activator was blocked by inclusion of cycloheximide, but not warfarin, in the culture medium. These results demonstrate that endothelial function is perturbed in a selective manner in the presence of low concentrations of oxygen, providing insights 
Introduction
Hypoxemia is a frequent feature of disorders ofthe circulatory system, especially those associated with ischemic cardiovascular disease. The effects of low concentrations of oxygen on cellular functions are quite complex, and include changes in a spectrum of cellular properties ranging from redirection of protein synthesis with the expression of oxygen-regulated pro- teins (1) (2) (3) (4) to the production of a,-adrenergic receptors and mitogens/inhibitors for smooth muscle cell growth (5) (6) (7) (8) . Thus, concomitant with the well-known hypoxia-mediated enhancement of glycolysis and suppression of aerobic metabolism (9, 10) , biosynthetic processes and changes in receptor expression are set into motion which can actively modulate cellular phenotype.
Of the many changes in homeostatic mechanisms in hypoxemia, two are of particular clinical importance: increased vascular permeability and a prothrombotic tendency (1 1-18) . The clinical consequences of these perturbations of vascular function are evident in the pulmonary edema which results from the hypoxia of high altitude, and the cerebral edema which may occur in hypoxemia ( 1 1 -15) . Furthermore, formation of venous thrombi is closely associated with the development of severe local hypoxemia in venous circulation (16) (17) (18) . Since endothelium has a major role in the regulation of barrier function and intravascular coagulation, we have examined the effects of hypoxemia on these cells which form the luminal vascular surface.
We have exposed cultured bovine aortic endothelium to low concentrations of oxygen and assessed permeability of the monolayer and cell surface coagulant properties. Our studies indicate that hypoxia increases endothelial permeability and shifts the balance of cell surface coagulant properties, producing a Factor X activator that promotes coagulation and suppressing the anticoagulant cofactor thrombomodulin. These observations suggest that hypoxic endothelium may contribute to the pathogenesis of vascular disorders in which intravascular oxygen concentrations are decreased.
Methods
Culture ofendothelial cells and conditions for achieving hypoxia. Bo- vine aortic endothelial cells were grown from aortas of newborn calves in minimal essential medium supplemented with penicillin-streptomycin (50 U/ml-5 Ag/ml), Hepes (pH 7.4; 10 mM), glutamine and fetal calfserum (10%; HyClone Laboratories, Logan, UT.) as described ( 19, 20) . Cultures were characterized as endothelial based on morphologic criteria, and immunofluorescence for protein S, von Willebrand factor, and thrombomodulin (21) (22) (23) . Cells were separated for subculture with trypsin/EDTA. For experiments, cells from different aortas were grown to confluence in 9.6-cm2 wells (Becton-Dickinson Labware, Lincoln Park, NJ; Lux Permanox, Miles Laboratories, Inc., Naperville, IL) and used from passages 3-16. Permeability studies employed cultures grown as described previously (24) on 6.5-mm diam polycarbonate membranes (pore size 0.4 zm), mounted on polystyrene inserts (Transwell plates, Costar Data Packaging Corp., Cambridge, MA), and used for studies 14 d after plating. Cultures were characterized based on cell density, determined using a Coulter counter (model ZM, Coulter Electronics, Luton, England), time in culture, and labeling index, using a kit from Amersham Corp. (Arlington Heights, IL). For experiments, endothelial cultures were grown to confluence (7) (8) (9) (10) air atmosphere, and then transferred to the hypoxia chamber for further study.
Confluent endothelial cultures were made hypoxic by removing the growth medium and substituting it with fresh medium which had been equilibrated with a gas mixture containing the desired concentration of oxygen (the balance of the atmosphere was made up by 5% carbon dioxide and nitrogen). Before adding this medium to the cells, dissolved gas analysis was performed (model ABL-2, Radiometer, Copenhagen, Denmark). Cultures were maintained under hypoxia using either sealed glass desiccators (equilibrated with an atmosphere containing the desired gas concentrations) placed in a 370C oven or an incubator attached to the hypoxia chamber (see below) which could maintain a humidified atmosphere with low oxygen concentrations (Coy Laboratory Products, Ann Arbor, MI; Forma Scientific, Marietta, OH). This apparatus established the hypoxic atmosphere by purging the chamber with a mixture containing the desired concentration of gases (02, N2, CO2). The oxygen content was continuously monitored and regulated using an oxygen analyzer which controlled an automated valve system. At the indicated times, cultures were placed in the hypoxia chamber (Coy Laboratory Products), an airtight glove box, in which experiments were carried to completion without exposing endothelium to ambient air. At intervals throughout these experiments, the oxygen content of culture medium bathing the cells was repeatedly analyzed. Values shown in the figures are the oxygen pressure ofthe medium. During the course of these experiments, pH of the medium remained constant. In certain experiments, either cycloheximide (0.1 g/ml for 48 h; Sigma Chemical Co., St. Louis, MO) or the warfarin derivative 3(a-acetonyl benzyl)-4-hydroxycoumarin (1 Mug/ml; Sigma Chemical Co.) was added to the growth medium during the incubation period under hypoxic conditions.
The protocols used included exposure to several levels of hypoxia (Po2's of 12, 19, 47, 147 mm Hg) for variable periods of time (12, 24, 48, 72, 82, 96, 120 h).
Release of lactate dehydrogenase into the medium by endothelial cells exposed to hypoxia was evaluated using a commercially available kit (Sigma Chemical Co.).
Endothelial monolayers were incubated with purified recombinant human tumor necrosis factor/cachectin-a (st 108 U/mg; generously provided by Dr. P. Lomedico, Hoffmann-LaRoche, Inc., Nutley, NJ) and tissue factor activity was studied as described below.
Determination of endothelial monolayer permeability. Confluent endothelial monolayers plated on Transwell inserts (see above) were exposed to hypoxia, washed with Earle's balanced salt solution, and then minimal essential medium containing fetal calf serum (5%) was added (all solutions were equilibrated with the gas mixture being used for that experiment and were carried out in the hypoxia chamber). Medium was added to both the inner and outer (corresponding to upper and lower) chambers so that the oncotic and hydrostatic pressures in the two chambers remained equal. A radiolabeled marker was then added at trace concentrations, either [3H]inulin (3 Mg/ml, 271 mCi/g; New England Nuclear, Boston, MA), [3Hlsorbitol (38 ng/ml, 24 Ci/mmol; New England Nuclear), or '25l-albumin (150 ng/ml, 5,000 cpm/ng), to the upper chamber. Radiolabeled albumin was prepared by the lactoperoxidase method (25) using Enzymobeads (BioRad Laboratories, Sacramento, CA), desalted on a Sephadex G25 column (Pharmacia, Inc., Piscataway, NJ) and dialyzed exhaustively against Hanks' balanced salt solution. The final product used for permeability studies was > 95% precipitable in 10% trichloroacetic acid. The volume of fluid in the chambers was not changed significantly (< 5%) as a result of sampling of wells during the experiment. Transport of tracers from the inner to outer chamber, i.e., across the endothelial monolayer, was determined by dividing radioactivity emerging in the outer well by radioactivity in remaining in the inner well (measured from duplicate 0.005-ml samples from each well).
Assessment of endothelial coagulant properties. Endothelial thrombomodulin activity and antigen were assessed after exposing cultures to hypoxia, as described previously (23, 26) . In brief, functional assays for cell surface thrombomodulin were performed by washing cultures four times with Hanks' balanced salt solution, and then incubating for 60 min at 370C in 10 mM Hepes, pH 7.45, 137 mM NaCI, 11 mM glucose, 4 mM KCI, 2 mM CaCI2, and 2 mg/ml bovine serum albumin containing protein C (1OOMg/ml) and thrombin (0.1 U/mi). The assay was carried out in the hypoxia chamber in the same atmosphere to which the cultures had been previously exposed and all buffers were preequilibrated with this gas mixture. Formation of activated protein C was terminated by the addition ofantithrombin III (100 Ag/ml) and the amount of enzyme formed was determined using a chromogenic assay, hydrolysis of the substrate Lys-Pro-Arg-pnitroanilide (Spectrozyme, American Diagnostica, NY). Enzyme concentration was determined by comparison with a standard curve made in the presence of known amounts of activated protein C. This assay has been described previously (26) . Protein C, antithrombin III (inhibitory activity of 1 U thrombin per Mg), and thrombin (2,500 U/mg) were prepared by standard procedures (27) (28) (29) . Each of these purified proteins was homogeneous on SDS-PAGE (30) .
Total thrombomodulin antigen was assessed by radioimmunoassay of endothelial cell detergent lysates (1% NP-40) prepared in the presence of protease inhibitors, phenylmethylsulfonyl fluoride (PMSF, 2 mM; Sigma Chemical Co.) and leupeptin (0.3 mM; Boehringer Mannheim Diagnostics, Inc., Houston, TX). The radioimmunoassay was carried out by a modification of the procedure described for human Factor IX (31), which is similar to that of Moore et al. (32) . In brief, the assay was performed in 1.5-ml microcentrifuge tubes by adding '25I-bovine thrombomodulin (5 (25) , using EnzymoBeads. Antibody to thrombomodulin was prepared in rabbits by standard methods (34) . The sensitivity of the thrombomodulin radioimmunoassay was 10 ng/ml, which corresponded to 80% binding on the standard curve. Using this assay, the thrombomodulin content of untreated endothelial cultures was -40-60 ng/ 106 cells.
Levels of thrombomodulin antigen were compared with total protein synthesis and fibronectin production. The effect of hypoxia on overall protein biosynthesis was assessed by evaluating cellular incorporation of [3Hlleucine (60 Ci/mmol; New England Nuclear) into trichloroacetic acid precipitable material using the method described by Madri et al. (35) . Briefly, [3H]leucine (20 MCi) was added to hypoxic cultures 12 h before harvesting the cells. 12 h later, the supernatant and cells were precipitated in ice cold trichloroacetic acid (10%). After 24 h at 4°C, the precipitates were collected and washed by filtration over Whatman No. I filter paper (Whatman Inc., Clifton, NJ). The papers were placed in vials, scintillation cocktail was added (Aquassure, New England Nuclear) and the mixtures were counted in a RackBeta counter (LKB Instruments, Inc., Gaithersburg, MD). Endothelial elaboration of fibronectin was assessed by obtaining aliquots of culture supernatant, and determining their fibronectin content by radioimmunoassay. The radioimmunoassay for fibronectin was carried out by the same procedure described above for thrombomodulin except that the tracer was '251I-bovine fibronectin, the antibody was a polyclonal antibovine fibronectin (Calbiochem-Behring Corp., San Diego, CA), and the incubation of first antibody with the assay mixture was for 8 h at 25°C. Purified bovine fibronectin, also obtained from CalbiochemBehring Corp., was radiolabeled by the lactoperoxidase method as described above for albumin. The sensitivity of the fibronectin radioimmunoassay was 0.2 Mg/ml, which corresponded to 80% binding on the standard curve.
Northern blots to assess levels of thrombomodulin and fibronectin mRNA were carried out by extracting total RNA from cells using the guanidinium thiocyanate procedure (36) , electrophoretic fractionation of the RNA on a 1.2% agarose gel (37), and transfer to nitrocellulose. cDNA probes for thrombomodulin (generously provided by Dr. E. Sadler, Wash University, St. Louis, MO) (38) and fibronectin (generously provided by Dr. R. Hynes, Massachusetts Institute of Technology, Cambridge, MA) (39) were labeled using random hexamer labeling (random primed DNA labeling kit, Boehringer Mannheim Biochemicals, Indianapolis, IN). Hybridization of cDNA probes to normal and hypoxic RNA was performed at 420C as described previously (40).
Study of endothelial cell procoagulant properties was carried out using coagulant and amidolytic assays. The coagulant assay was performed on either intact monolayers (9.6 cm2) or cells scraped with a rubber policeman to obtain a suspension (; 106 cells/ml). The cells in suspension were > 90% viable, based on trypan blue exclusion. The cells were washed three times with veronal buffer (once with veronal buffer containing 5 mM EDTA over 3 min and twice with veronal buffer without EDTA) and then 0.2 ml of the same buffer was added along with citrated bovine plasma (0.2 ml) and CaCl2 (20 mM, 0.2 ml), and the mixture was incubated at 370C for the first visual evidence of a fibrin clot. The Factor Xa clotting assay was performed by incubating purified Factor X (50 ;&g/ml) with hypoxic or normoxic endothelial cells for the indicated times, removing aliquots (60 d1) and adding them to Factor VII/X-deficient bovine plasma (60 ALI, Sigma Chemical Co.) along with cephalin (60 !d) and CaCI2 (20 mM, 60 1Al). Enzyme concentration was determined by comparison with a standard curve made with known amounts of Factor Xa. The amidolytic assay for Factor Xa (41) was performed by incubating endothelium with Factor X (50 yg/ml) and testing aliquots of reaction medium for Factor Xa activity with the chromogenic substrate methoxycarbonyl-o-cyclohexyl-Gly-Gly-Arg-p-nitroanilide (Spectrozyme FXa, American Diagnostica). Change in optical density at 405 nm was measured and compared with a standard curve generated with purified Factor Xa. This assay was sensitive to 0.4-0.5 nM Factor Xa. Where indicated, after the initial exposure to hypoxia, endothelial cells were further incubated in the same hypoxic environment in the presence of either antibody to tissue factor (10 Mg/ml, I h at 370C) (blocking anti-bovine tissue factor monoclonal antibody was generously provided by Dr. R. Bach, Mt. Sinai School of Medicine, New York) (42), mercury chloride (0.1 mM, 30 min at 370C), or PMSF( I mM, 30 min at room temperature) before carrying out the coagulant assay. Cultures were then washed extensively and the Factor X activation assay was performed. Activation of Factor X by hypoxic endothelium was also studied by examining cleavage of 1251I-Factor X on SDS-PAGE. Endothelial cultures, normoxic or hypoxic, were incubated with radiolabeled Factor X and samples were prepared for reduced SDS-PAGE (30) .
For these studies Factors X (100 U/mg), IX (220 U/mg), and prothrombin (13 U/mg) were purified to homogeneity by previously described methods (27, 43, 44) . Purified Factor X had no detectable Factor VII activity: prolonged incubation with tissue factor did not lead to Factor Xa formation. Factor X was radiolabeled by the lactoperoxidase method using Enzymobeads as described previously for albumin. '251-Factor X was > 95% precipitable in 10% trichloroacetic acid and had a specific radioactivity of 5,000 cpm/ng. Factor X and radiolabeled Factor X were activated by incubation with Russell's viper venom (ratio of 1:100 for enzyme to substrate, generously supplied in purified form by Dr In one experiment, the procoagulant activity of tumor necrosis factor/cachectin-treated endothelium was examined using a two-stage plasma recalcification clotting assay, as described previously (26, 45) . Inhibition ofendothelial tissue factor induced by tumor necrosis factor (26, 46) was studied with purified antibody to tissue factor (10 Mg/ml).
To examine modulation of vessel wall coagulant properties using fresh native endothelium, an experiment was carried out with aortic segments obtained from calves immediately after sacrifice (Max Cohen, Inc., New York). The vessel segments were incubated for 24 h in complete endothelial growth medium and exposed either to a normoxic or hypoxic (Po2 14 mm Hg) humidified environment containing 5% CO2. Then, the segments were washed with Hanks' balanced salt solution (first with and then without 5 mM EDTA), placed in a template device, and functional assays for thrombomodulin and the Factor X activator were carried out as described above for cultured cells. Hypoxic vessel segments were maintained in the hypoxic atmosphere during the entire assay period. The template device consisted of two sheets of lucite, a top sheet with regularly spaced holes (surface area 1.5 cm2) and a solid bottom sheet. Vessel segments were placed between the two sheets of the template such that watertight wells with exposed native endothelium were formed. This system has been described by us previously (47) .
Results
General properties and barrierfunction ofhypoxic endothelial cultures. Endothelial cell cultures tolerated the hypoxic environment (as low as Po2 14 mm Hg) well with no evidence of cell death, based on trypan blue exclusion and lactate dehydrogenase release, up to the longest incubation times examined, 4-5 d. This is consistent with previous observations (10) . However, monolayers maintained in hypoxic conditions did exhibit alterations in the actin-based cytoskeleton and cell shape.
Cells exposed to hypoxia (P02 14 mm Hg) for 24 h appeared flatter, their peripheral bands of circumferential stress fibers appeared diffuse, and in the central cytoplasm reticular networks of thin actin filaments developed, compared with normoxic controls. These changes became more accentuated by 48 h. Concomitant with alterations in the actin-based cytoskeleton, multiple small gaps developed between apposing cells evident by scanning electron microscopy. Each of these changes was reversible, and within 48 h of return to an ambient air atmosphere cultures closely resembled their normoxic counterparts.
The presence of intercellular gaps in the monolayer suggested that barrier function would be perturbed. Confluent endothelial monolayers grown on microporous polycarbonate membranes form a barrier restricting the passage of macromolecules and lower molecular weight solutes (Fig. 1, A and B ) (24, (48) (49) (50) . Using this experimental system, cultures shifted to hypoxia (Po2 14 mm Hg) demonstrated an increase in the passage of macromolecular tracers across the monolayer. The hypoxia-induced diffusional defect was dependent on both the amount of time cultures were incubated under hypoxic conditions (Fig. 1 A) and the degree of hypoxia (Fig. 1 B) (Fig. 1 A) (Fig. 2 B) . To examine mechanisms by which hypoxia suppressed thrombomodulin, first the effect of hypoxia on total protein synthesis was studied. Based on the incorporation of [3H]leucine into material precipitable in trichloroacetic acid, endothelial protein synthesis fell within 12 hr of exposure to hypoxia (Fig. 2 A) , and reached its lowest levels after 24-48 h (a decline of -40% compared with normoxic cultures). In contrast, although thrombomodulin initially fell more slowly, by 48 h the decline was much greater. These results suggest that there might be a selective suppression of thrombomodulin in hypoxia. This interpretation was further supported by experiments demonstrating that another, unrelated macromolecular product of endothelium, fibronectin, was produced in normal or even slightly increased amounts in hypoxia (Fig. 3 A) . Finally, Northern blots of endothelial RNA hybridized with cDNA probes for thrombomodulin and fibronectin showed a marked decrease in thrombomodulin, but not fibronectin mRNA (Fig.  3 B) .
Suppression of thrombomodulin in hypoxic endothelial cells was reversible: levels of thrombomodulin activity/antigen approaching (even exceeding) that of normoxic controls were observed within 48 h of restitution of an ambient air atmosphere (Fig. 2 A) .
Hypoxia-mediated induction of endothelial procoagulant activity: induction ofa Factor X activator. Exposure of endothelial cultures to hypoxic conditions induced clot-promoting activity, assessed by a shortening of the recalcification time of plasma (Fig. 4) . Expression of cell surface procoagulant activity was dependent on the time cultures were maintained in hypoxic conditions, being evident by 24 h and maximal by 72 h (Fig. 4 A) (Fig. 4 C) , failed to affect the clotting time of h lium (Fig. 4 C) . These results suggested that activity other than tissue factor was responsit ened clotting time observed with hypoxic en possibility that hypoxic endothelium was di Factor IX or prothrombin was tested by addii coagulation proteins to hypoxic endotheliur activation was evident (based on coagulant, and, for thrombin, FN amidolytic assays) and no cleavage was observed on SDS-N H PAGE using radiolabeled tracers.
Studies with purified Factor X showed direct activation of - (52) (Fig.   ) n of fibronectin 5, lane C) on reduced SDS-PAGE. In contrast, neither buffer In by hypoxic encontrols (Fig. 5, lane A) nor normoxic cultures cleaved Factor rs were incubated X (Fig. 5, lane B) . Control activation mixtures with Russell's glid line) environviper venom and the same Factor X preparation demonstrated im was detercleavage of Factor X with a predominance of the Factor Xaa Kt. Data shown heavy chain, as has been reported previously (53) (Fig. 4, A and B) . Similar results message is bewere obtained when Factor Xa formation was assessed using (Fig. 4 B) .
Factor IX, nor Factor VIII had any effect on Factor X activaating that expotion (data not shown). In addition, Factor X activation by s and endotoxin hypoxic endothelium was studied after washing cultures with xamine whether EDTA-containing buffer under conditions which completely procoagulant ac-remove cell-associated Factor IX/IXa (47) .
vine tissue factor To characterize better the nature of the endothelial procorse the procoaguagulant activity resulting in Factor Xa formation under hypendothelial cells oxic conditions (Fig. 7) , we first determined whether the FacLypoxic endothetor X activator of hypoxic endothelium was present in culture t a procoagulant supernatants or was localized to cell membrane (Fig. 7 A) : ble for the shortsupernatants of hypoxic endothelium did not activate Factor idothelium. The X, rather, the Factor X activator was concentrated in cell irectly activating membrane preparations. Similar cell preparations from norng these purified moxic cultures, in contrast, did not activate Factor X (Fig. 7 n. However, no A). Expression of the Factor X activator could be blocked by (1) (2) (3) (4) (5) (6) (7) (8) 54 ). In our studies, alterations in protein expression appeared to underlie the effects of hypoxia on two endothelial cell surface coagulant properties, suppression ofthrombomodulin and induction of a new procoagulant activity not observed in normoxic cultures. Decreased expression of thrombomodulin during hypoxia was a striking finding, since levels were only 20% of that observed in controls.
Based on the considerable decrease in levels of thrombomodulin mRNA in hypoxic cultures, it seems likely that lower rates of thrombomodulin synthesis contribute to its reduction under these conditions. Other mechanisms, however, such as shedding of cell surface thrombomodulin or increased degradation, could also be involved. In this context, pilot studies did not demonstrate shedding of thrombomodulin antigen from the surface of hypoxic endothelium using antigenic and functional assays (data not shown). Furthermore, addition of chloroquine to cultures, an agent which has been shown to prevent tumor necrosis factor/cachectin-induced endothelial degradation of thrombomodulin antigen (32) , had no effect on hypoxia-induced attenuation of thrombomodulin.
In addition to reduced thrombomodulin, hypoxia induced synthesis and expression of a membrane-associated activator of Factor X. Although the identity ofthis Factor X activator is unclear, it does not appear to be part ofthe intrinsic or extrinsic pathways, and most closely resembles the tumor procoagulant (60, 61) . The latter enzyme has been purified and shown to be a membrane-associated cysteine proteinase identified in certain malignant tissues. The hypoxic Factor X activator is inhibited by mercury chloride, but not PMSF, which is similar to the tumor procoagulant. Furthermore, both the hypoxic Factor X activator (data not shown) and the tumor procoagulant (61) can be eluted from membranes in the presence of veronal buffer (20 mM, pH 7.8) . The Km of the enzyme expressed by hypoxic endothelium for the substrate is similar to that of the intrinsic Factor X activation complex and close to the plasma concentration of Factor X (41). However, under the conditions examined in the current experiments Vma. is lower with the hypoxic Factor X activator than the Factor IXa-VIIIa complex (41) . Although this might suggest that hypoxic endothelium would not be an important contributor to Factor X activation in vivo, pilot studies have shown that when the pH is lowered, which frequently occurs with hypoxemia owing to decreased blood flow, Vmax increases and Km decreases (data not shown). In addition, local hypoxemia and stasis in venous thrombotic disease could potentially favor accumulation of Factor Xa formed by the hypoxic endothelial Factor X activator. Thus, alterations in the endothelial milieu may modulate the effectiveness of the Factor X activator. Consistent with the results obtained in vitro, hypoxic native endothelium in aortic segments expressed a Factor X activator and demonstrated decreased thrombomodulin activity.
Although the in vivo physiologic relevance of these findings in cell culture has yet to be examined, they may provide a basis for understanding the initiation of vascular pathology under hypoxic conditions, as manifested by increased permeability, as well as a prothrombotic tendency. An association between vessel wall hypoxemia and thrombosis has long been suspected: Sevitt ( 16) indicated 20 yr ago that thrombi formed in venous valve pockets, an area subject to stasis and hypoxemia (17) . Moreover, the observation that the clot was attached to the vessel surface of the valve cusps raised speculation that hypoxia-induced alterations in endothelial cell function could play an important role in the pathogenesis of thrombosis (18) . Furthermore, by providing insights into pathways of hypoxic vascular injury, in vitro endothelial studies should facilitate the identification and evaluation of protective agents which may ultimately prove useful in vivo.
